Chevy Chase Trust Holdings LLC raised its stake in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 0.7% during the 2nd quarter, according to its most recent filing with the SEC. The firm owned 81,971 shares of the semiconductor company’s stock after acquiring an additional 600 shares during the period. Chevy Chase Trust Holdings LLC owned approximately 0.05% of Synopsys worth $42,025,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Vanguard Group Inc. lifted its stake in Synopsys by 2.4% during the 1st quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock valued at $6,359,747,000 after acquiring an additional 346,994 shares during the period. Pictet Asset Management Holding SA lifted its stake in Synopsys by 38.3% during the 1st quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock valued at $1,043,518,000 after acquiring an additional 673,837 shares during the period. Ameriprise Financial Inc. lifted its stake in Synopsys by 6.6% during the 1st quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock valued at $863,500,000 after acquiring an additional 125,199 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its stake in Synopsys by 20.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock valued at $778,928,000 after acquiring an additional 305,489 shares during the period. Finally, Alliancebernstein L.P. lifted its stake in Synopsys by 22.2% during the 1st quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock valued at $739,857,000 after acquiring an additional 313,218 shares during the period. Institutional investors own 85.47% of the company’s stock.
Synopsys Trading Up 1.7%
Synopsys stock opened at $447.64 on Friday. The firm has a 50 day moving average of $525.72 and a 200 day moving average of $510.23. The firm has a market capitalization of $83.15 billion, a price-to-earnings ratio of 35.14, a P/E/G ratio of 4.85 and a beta of 1.10. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The company has a current ratio of 1.62, a quick ratio of 1.51 and a debt-to-equity ratio of 0.52.
Insider Activity
In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the stock in a transaction that occurred on Tuesday, September 2nd. The shares were sold at an average price of $589.01, for a total transaction of $6,694,687.66. Following the completion of the sale, the chief executive officer directly owned 71,615 shares of the company’s stock, valued at $42,181,951.15. This trade represents a 13.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction that occurred on Friday, September 5th. The shares were sold at an average price of $609.77, for a total transaction of $2,228,709.35. Following the sale, the chief financial officer directly owned 15,317 shares of the company’s stock, valued at approximately $9,339,847.09. This trade represents a 19.27% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is owned by insiders.
Analyst Ratings Changes
Several equities analysts have issued reports on the stock. Stifel Nicolaus lowered their target price on shares of Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. JPMorgan Chase & Co. lowered their price objective on shares of Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. The Goldman Sachs Group lowered their price objective on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Wells Fargo & Company lowered their price objective on shares of Synopsys from $630.00 to $550.00 and set an “equal weight” rating on the stock in a research note on Wednesday, September 10th. Finally, Piper Sandler lowered their price objective on shares of Synopsys from $660.00 to $630.00 and set an “overweight” rating on the stock in a research note on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys currently has a consensus rating of “Hold” and a consensus price target of $569.67.
View Our Latest Research Report on Synopsys
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Recommended Stories
- Five stocks we like better than Synopsys
- What does consumer price index measure?
- This AI Chip Giant Could Be the Market’s Next Big Winner
- Why Invest in High-Yield Dividend Stocks?
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- Stock Analyst Ratings and Canadian Analyst Ratings
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.